{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:38:25Z","timestamp":1791412705836,"version":"4.3.3"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s12350-022-03111-4","type":"journal-article","created":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T17:19:11Z","timestamp":1666286351000},"page":"1075-1087","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Potential clinical utility of 68Ga-DOTATATE PET\/CT for detection and response assessment in cardiac sarcoidosis"],"prefix":"10.1016","volume":"30","author":[{"given":"Hwan","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin K.","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahesh K.","family":"Vidula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Pryma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis E.","family":"Marchlinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee R.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin B.","family":"Clancy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milton D.","family":"Rossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo F.","family":"DiCarli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paco E.","family":"Bravo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s12350-022-03111-4_bib1","doi-asserted-by":"crossref","first-page":"546","DOI":"10.5114\/aoms.2011.24118","article-title":"Cardiac sarcoidosis: a comprehensive review","volume":"7","author":"Sekhri","year":"2011","journal-title":"Arch Med Sci"},{"key":"10.1007\/s12350-022-03111-4_bib2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/MCP.0000000000000611","article-title":"Treatment of cardiac sarcoidosis","volume":"25","author":"Kouranos","year":"2019","journal-title":"Curr Opin Pulm Med"},{"key":"10.1007\/s12350-022-03111-4_bib3","first-page":"325","article-title":"Current and emerging pharmacological treatments for sarcoidosis: a review","volume":"7","author":"Beegle","year":"2013","journal-title":"Drug Des Devel Ther"},{"key":"10.1007\/s12350-022-03111-4_bib4","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s12350-018-01488-9","article-title":"Advanced cardiovascular imaging for the evaluation of cardiac sarcoidosis","volume":"26","author":"Bravo","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-022-03111-4_bib5","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ijcard.2017.03.033","article-title":"Risk assessment of patients with clinical manifestations of cardiac sarcoidosis with positron emission tomography and magnetic resonance imaging","volume":"241","author":"Bravo","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1007\/s12350-022-03111-4_bib6","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2967\/jnumed.111.090662","article-title":"The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience","volume":"53","author":"Youssef","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1007\/s12350-022-03111-4_bib7","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00259-007-0650-8","article-title":"Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis","volume":"35","author":"Ohira","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-022-03111-4_bib8","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s12350-016-0502-7","article-title":"Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation","volume":"24","author":"Osborne","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-022-03111-4_bib9","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1046\/j.1365-2362.1999.00498.x","article-title":"Immunohistochemical localization of somatostatin receptor sst2A in sarcoid granulomas","volume":"29","author":"ten Bokum","year":"1999","journal-title":"Eur J Clin Invest"},{"key":"10.1007\/s12350-022-03111-4_bib10","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s12350-019-01782-0","article-title":"Feasibility of somatostatin receptor-targeted imaging for detection of myocardial inflammation: A pilot study","volume":"28","author":"Bravo","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-022-03111-4_bib11","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1007\/s12350-019-01824-7","article-title":"Somatostatin receptor imaging in active cardiac sarcoidosis: Would less be enough?","volume":"28","author":"Zubin Maslov","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-022-03111-4_bib12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1634\/theoncologist.2020-0165","article-title":"(68) Ga-DOTATATE positron emission tomography-computed tomography quantification predicts response to somatostatin analog therapy in gastroenteropancreatic neuroendocrine tumors","volume":"26","author":"Lee","year":"2021","journal-title":"Oncologist"},{"key":"10.1007\/s12350-022-03111-4_bib13","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/ehjci\/jeaa299","article-title":"Procedural recommendations of cardiac PET\/CT imaging: standardization in inflammatory-, infective-, infiltrative-, and innervation- (4Is) related cardiovascular diseases: a joint collaboration of the EACVI and the EANM: summary","volume":"21","author":"Slart","year":"2020","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1007\/s12350-022-03111-4_bib14","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1093\/eurheartj\/ehv278","article-title":"Detection of cardiac sarcoidosis by macrophage-directed somatostatin receptor 2-based positron emission tomography\/computed tomography","volume":"36","author":"Reiter","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1007\/s12350-022-03111-4_bib15","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1007\/s12350-017-1178-3","article-title":"Gallium-68 DOTANOC scan in a patient with suspected cardiac sarcoidosis","volume":"25","author":"Passah","year":"2018","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-022-03111-4_bib16","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijcard.2015.05.073","article-title":"Imaging of myocardial inflammation with somatostatin receptor based PET\/CT: A comparison to cardiac MRI","volume":"194","author":"Lapa","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1007\/s12350-022-03111-4_bib17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s41824-017-0014-y","article-title":"Somatostatin receptor based hybrid imaging in sarcoidosis","volume":"1","author":"Slart","year":"2017","journal-title":"Eur J Hybrid Imaging"},{"key":"10.1007\/s12350-022-03111-4_bib18","doi-asserted-by":"crossref","first-page":"77807","DOI":"10.18632\/oncotarget.12799","article-title":"Somatostatin receptor based PET\/CT in patients with the suspicion of cardiac sarcoidosis: an initial comparison to cardiac MRI","volume":"7","author":"Lapa","year":"2016","journal-title":"Oncotarget"},{"key":"10.1007\/s12350-022-03111-4_bib19","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13550-016-0207-6","article-title":"A dual tracer (68)Ga-DOTANOC PET\/CT and (18)F-FDG PET\/CT pilot study for detection of cardiac sarcoidosis","volume":"6","author":"Gormsen","year":"2016","journal-title":"EJNMMI Res"},{"key":"10.1007\/s12350-022-03111-4_bib20","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/ehf2.12243","article-title":"Cardiovascular magnetic resonance imaging and clinical performance of somatostatin receptor positron emission tomography in cardiac sarcoidosis","volume":"5","author":"Pizarro","year":"2018","journal-title":"ESC Heart Fail"},{"key":"10.1007\/s12350-022-03111-4_bib21","doi-asserted-by":"crossref","first-page":"e416","DOI":"10.1097\/RLU.0000000000003185","article-title":"68Ga-DOTATOC PET for Treatment Efficacy Evaluation of Cardiac Sarcoidosis","volume":"45","author":"Imperiale","year":"2020","journal-title":"Clin Nucl Med"},{"key":"10.1007\/s12350-022-03111-4_bib22","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1088\/0031-9155\/59\/14\/3843","article-title":"Performance evaluation of the Ingenuity TF PET\/CT scanner with a focus on high count-rate conditions","volume":"59","author":"Kolthammer","year":"2014","journal-title":"Phys Med Biol"},{"key":"10.1007\/s12350-022-03111-4_bib23","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/hc0402.102975","article-title":"Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association","volume":"105","author":"Cerqueira","year":"2002","journal-title":"Circulation"},{"key":"10.1007\/s12350-022-03111-4_bib24","article-title":"Myocardial uptake of (68)Ga-DOTATATE: correlation with cardiac disease and risk factors","author":"Itani","year":"2021","journal-title":"Acta Radiol"},{"key":"10.1007\/s12350-022-03111-4_bib25","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/j.jacc.2017.01.060","article-title":"Detection of atherosclerotic inflammation by (68)Ga-DOTATATE PET compared to [(18)F]FDG PET imaging","volume":"69","author":"Tarkin","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-022-03111-4_bib26","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1016\/j.jacc.2019.02.052","article-title":"(68)Ga-DOTATATE PET identifies residual myocardial inflammation and bone marrow activation after myocardial infarction","volume":"73","author":"Tarkin","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-022-03111-4_bib27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13550-020-0601-y","article-title":"Standardized image quality for (68)Ga-DOTA-TATE PET\/CT","volume":"10","author":"Cox","year":"2020","journal-title":"EJNMMI Res"},{"issue":"1","key":"10.1007\/s12350-022-03111-4_bib28","doi-asserted-by":"crossref","first-page":"i2","DOI":"10.1136\/hrt.2005.077875","article-title":"Anatomy, echocardiography, and normal right ventricular dimensions","volume":"92","author":"Ho","year":"2006","journal-title":"Heart"},{"key":"10.1007\/s12350-022-03111-4_bib29","first-page":"1758","article-title":"The role of myocardial wall thickness in atrial arrhythmogenesis","volume":"18","author":"Whitaker","year":"2016","journal-title":"Europace"},{"key":"10.1007\/s12350-022-03111-4_bib30","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s12149-016-1095-6","article-title":"The utility of PET\/CT with (68)Ga-DOTATOC in sarcoidosis: comparison with (67)Ga-scintigraphy","volume":"30","author":"Nobashi","year":"2016","journal-title":"Ann Nucl Med"},{"key":"10.1007\/s12350-022-03111-4_bib31","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/MNM.0000000000000869","article-title":"Gallium-68 DOTA-NOC PET\/CT as an alternate predictor of disease activity in sarcoidosis","volume":"39","author":"Sharma","year":"2018","journal-title":"Nucl Med Commun"},{"key":"10.1007\/s12350-022-03111-4_bib32","doi-asserted-by":"crossref","first-page":"e008975","DOI":"10.1161\/CIRCIMAGING.118.008975","article-title":"Diagnostic Accuracy of Advanced Imaging in Cardiac Sarcoidosis","volume":"12","author":"Divakaran","year":"2019","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1007\/s12350-022-03111-4_bib33","first-page":"7457369","article-title":"Cardiac magnetic resonance imaging for diagnosis of cardiac sarcoidosis: A meta-analysis","volume":"2018","author":"Zhang","year":"2018","journal-title":"Can Respir J"},{"key":"10.1007\/s12350-022-03111-4_bib34","first-page":"311","article-title":"Somatostatin receptor PET ligands - the next generation for clinical practice","volume":"8","author":"Pauwels","year":"2018","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-022-03111-4_bib35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13550-017-0321-0","article-title":"Comparative evaluation of (18)F-FLT and (18)F-FDG for detecting cardiac and extra-cardiac thoracic involvement in patients with newly diagnosed sarcoidosis","volume":"7","author":"Norikane","year":"2017","journal-title":"EJNMMI Res"},{"key":"10.1007\/s12350-022-03111-4_bib36","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s13550-020-00742-x","article-title":"FLT-PET for the assessment of systemic sarcoidosis including cardiac and CNS involvement: A prospective study with comparison to FDG-PET","volume":"10","author":"Martineau","year":"2020","journal-title":"EJNMMI Res"},{"key":"10.1007\/s12350-022-03111-4_bib37","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1016\/j.jcmg.2019.06.020","article-title":"imaging cardiac sarcoidosis with FLT-PET compared with FDG\/perfusion-PET: A prospective pilot study","volume":"12","author":"Martineau","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1007\/s12350-022-03111-4_bib38","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/RLU.0000000000000653","article-title":"18F-FLT PET imaging in a patient with sarcoidosis with cardiac involvement","volume":"40","author":"Norikane","year":"2015","journal-title":"Clin Nucl Med"},{"key":"10.1007\/s12350-022-03111-4_bib39","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1007\/s12350-019-01976-6","article-title":"(18)F-FMISO PET\/CT detects hypoxic lesions of cardiac and extra-cardiac involvement in patients with sarcoidosis","volume":"28","author":"Furuya","year":"2021","journal-title":"J Nucl Cardiol"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-022-03111-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12350-022-03111-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123000235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123000235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-022-03111-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:11:19Z","timestamp":1761027079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358123000235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S1071358123000235"],"URL":"https:\/\/doi.org\/10.1007\/s12350-022-03111-4","relation":{},"ISSN":["1071-3581"],"issn-type":[{"value":"1071-3581","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential clinical utility of 68Ga-DOTATATE PET\/CT for detection and response assessment in cardiac sarcoidosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12350-022-03111-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2023 American Society of Nuclear Cardiology. Published by ELSEVIER INC. All rights reserved. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}